October 1, 2021
ECRI partners with FDA on safety of materials in medical devices
Editor's Note
ECRI, on September 30, announced a new partnership with the Food and Drug Administration (FDA) to improve the safety of medical devices through the use of safer materials.
ECRI is developing safety reports for materials commonly used in implantable medical devices and assessing their possible effects on patients over time.
The first four reports are available now on FDA.gov: magnesium, polypropylene, polyurethanes, and siloxanes.
Free Daily News
- Study: ERAS protocol reduces opioid use after cardiac surgery
- Study: Prehabilitation reduces surgical complications, speeds recovery
- Commentary: Studies show how surgeon decisions follow the money
- Proposed HIPAA updates would improve cybersecurity, increase costs for healthcare providers
- Study: EMR data can enhance hand hygiene compliance, infection prevention
- Study: Machine learning model improves perioperative pain assessment
- Call for improved suicide risk screening in ASCs aims to strengthen safety protocols
- Study: Perioperative pregabalin reduces risk of kidney decline compared to gabapentin
- Medical school diversity declines after Supreme Court ruling
- Surgeons risk losing ground as transcatheter tricuspid valve interventions rise
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement